Trusted by many physicians, Khure Health’s AI-Enabled Clinical Intelligence platform works.
Khure Health is a great resource to my practice. It provides insights into rare diseases that I probably would not have considered. It provides a short list of patients to consider for rare diseases by searching my clinical database, recommends the next steps, and provides the necessary education material to make an appropriate clinical decision
... Advanced AI-enabled Solutions, such as tech like Khure Health's clinical intelligence platform, harnesses the power of artificial intelligence [AI] to capitalize on the vast amounts of patient data in EMRs, enabling the potential diagnosis and hopefully improved treatment and quality of life for the patient. It is anticipated that identification of rare disease in patients and care pathway optimization technologies will play an even larger role in clinical decision support in the future.
The Khure Health program helped me successfully identify a patient in my practice who was undiagnosed and suffering from Hereditary Spherocytosis. I am happy to say this patient is now working with a specialist to get the care they need. We need more tools like this to help us quickly and efficiently identify undiagnosed or misdiagnosed patients within our practices. With early identification and intervention, I now have the ability to better serve my patients. The Khure Health team was wonderful in supporting me throughout this process, and helped me easily understand my options for next steps in my patient's care.
Previous
Next
Using AI to augment physician intelligence, skill and experience is a powerful combination. This is where innovative technology intersects with compassionate care so that no patient falls through the cracks.
With Khure Health, we can do more.
Advanced AI Clinical Intelligence now put into practice
By channeling the power of AI, Khure Health is able to swiftly identify potentially high-risk rare disease patients, as well as accelerate patient recruitment for clinical trials.